DuChemBio buys land for Jeongeup production facility, full-scale investment of ₩34.3B
Predicted impact: Low
Land purchase for a ₩34.3B facility is small versus the company's ₩200B market value and is routine.
DuChemBio듀켐바이오
176750 · KOSDAQ · ₩176750 · 듀켐바이오
₩6,400▼ ₩760 (10.61%)End-of-day · Oct 29, 2026 · End-of-day prices.
Next Trade Halts Trading in Bumhan Fuel Cell and Duchem Bio from the 26th as Volume Exceeds Korea Exchange
Predicted impact: Low
Trading halt on the alternative exchange due to volume; small, company-specific but limited impact.
[Yeouido Investment Division Part 2] Samsung Electro-Mechanics vs. Samsung SDI vs. Studio Dragon vs. Duchem Biotech — What's the Strategy?
Predicted impact: Low
Stock-picking TV segment; Studio Dragon already featured in similar items recently.
Black Thursday: DuChemBio, Yuhan and Curiox Emerge as Rare Bright Spots [K-BIO Pulse]
Predicted impact: Low
Market wrap listing winners; repeats the Lilly Alzheimer's drug expectations already covered in recent days.
Only 21 of 253 Rise, 'Wipeout'... DuChemBio, Yuhan and Curiox Were the Winners [Bio Stock Check]
Predicted impact: Low
Market wrap listing winners; repeats the Lilly Alzheimer's drug expectations already covered in recent days.
[Hit! Big Win Hunch] 'Duchem Bio, HMM, Curioxbiosystems' - good-feeling big-win stocks for tomorrow's market?
Predicted impact: Low· Actual: +3.6% vs sector, volume 5.4× normal (5 trading days)
DuChemBio Surges on Expectations for Lilly's Alzheimer's Drug Approval
Predicted impact: Low· Actual: +28.5% vs sector, volume 19.2× normal (5 trading days)
Same Lilly approval expectation story as earlier item; repeat of the same news.
[Stocks in Focus] DuChemBio Jumps Over 10% on Hopes for Domestic Approval of Lilly's Alzheimer's Treatment
Predicted impact: Medium· Actual: +28.5% vs sector, volume 19.2× normal (5 trading days)
Shares jump over 10% on hopes of Lilly drug approval; sizable sentiment-driven move.
Also known as: DuChemBio / 듀켐바이오 / 176750 / KRX:176750
Source: KRX statistical information